Clinical Trial Update: Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine with Abraxane for potentially operable pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)

Snippet

Sponsor: Pancreatic Cancer Research Team | Conditions: Resectable Pancreatic Cancer | Phase 2 | Status: COMPLETED